Portfolio Companies 2026 for Gimv: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Gimv accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.3B. The median disclosed raise is $89M, and the largest is Mediar Therapeutics at $181M, ahead of ImCheck Therapeutics ($154M) and Kinaset Therapeutics ($150M).
The names that recur most often on these portfolio cap tables are Gimv (13 companies), Pfizer Ventures (4 companies), Andera Partners (3 companies), EQT Life Sciences (3 companies), Sofinnova Partners (2 companies), Mission BioCapital (2 companies). By latest disclosed round, the market skews Series B (6), Series A (3), Series C (2), IPO (1).